about
The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluationDiet, physical activity, and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 yearsDietary fibre for the primary prevention of cardiovascular diseaseParent-only interventions for childhood overweight or obesity in children aged 5 to 11 yearsSurgery for weight loss in adultsSurgery for obesitySurgery for morbid obesitySpecialist nurses in diabetes mellitusEducational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectivenessThe clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluationEar wax removal interventions: a systematic review and economic evaluationThe clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluationA systematic review of the clinical and cost-effectiveness of memantine in patients with moderately severe to severe Alzheimer's disease.The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.Time to full publication of studies of anticancer drugs for breast cancer, and the potential for publication bias.The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation.The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation.Topotecan for relapsed small cell lung cancer: a systematic review and economic evaluation.The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review.Bone-anchored hearing aids (BAHAs) for people who are bilaterally deaf: a systematic review and economic evaluation.Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation.Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.Endocrinology trial design: adverse event reporting in randomised controlled trials of recombinant human GH in GH-deficient adults.Screening for gestational diabetes: a systematic review and economic evaluation.The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation.The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation.The effectiveness of diagnostic tests for the assessment of shoulder pain due to soft tissue disorders: a systematic review.Comparing new treatments for idiopathic pulmonary fibrosis--a network meta-analysis.Accuracy of fundus autofluorescence imaging for the diagnosis and monitoring of retinal conditions: a systematic review.Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation.Systematic review of cognitive behavioural therapy for the management of headaches and migraines in adults.The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review.Fundus autofluorescence imaging: systematic review of test accuracy for the diagnosis and monitoring of retinal conditions.The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation.Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic review and economic evaluation.The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation.Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation.Cost-effectiveness of left ventricular-assist devices in end-stage heart failure.The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review.
P50
Q21195756-57A5B70F-6152-4E3B-BCBA-1555CCA4604EQ24186038-A5F5C2B5-FC97-4322-99CF-122DDB608949Q24186550-A322C833-5FBB-4BB8-858B-55152CDA5BC4Q24187023-0E02CE89-9BDB-4F67-8493-C1EA971AFC6AQ24194419-FFE2C1B7-1D8E-4E80-B128-2DEEB36A2BE5Q24241212-E1FDC02F-66F5-47D1-A501-FBA518E75FD8Q24245694-BA9C4944-77AE-4F23-9BCE-4207C4819640Q24248727-64BF89F0-D007-41B4-85E6-2AAA9DB0020BQ26778903-DB89FAA1-82C0-426E-B4DF-76227724B4FDQ26852938-A98FA097-5114-4113-8A8C-12370614C89BQ26858907-03FEA6B7-2C57-4B7E-BD99-741530788855Q27026615-25368B14-5EA7-4FCB-A29B-722A1C0F9E49Q33239619-5F57EE19-FDF2-4EC3-907E-64985C86F02EQ33499561-1CC3E2EF-564F-4233-802E-FBEA7D2762FFQ33522784-CD3C464B-0EF2-4DD2-A209-C6A327E048F9Q33548199-FD39E4C5-5424-47F2-8103-8D6B0083C699Q33603843-7FA44E35-F3E7-44B6-98C5-3D8053E9BDF8Q33658120-58797C0A-529A-410D-8A3E-D3BC543F8095Q33797422-D85DAACC-E2A3-4B12-BDE7-5C7D72205F24Q33951260-946CEF56-D6CB-4B8D-925E-2D7FD3E30C3AQ34260552-7B6D3D7A-9785-4AAC-9196-91446B5DBC9CQ34473820-C4C60D2D-2AEE-401D-9C1E-755CEBED93F2Q34995280-A0AE71E5-3AE6-468A-BD8A-A6EE2820AC4CQ34998293-E552A283-F793-403F-A70A-0080CE1A9045Q35294578-2448DEE0-2209-4400-8B99-5FCD6E91E737Q35371904-D254D432-2261-46C0-B690-161D441D0765Q35563804-87545F9C-A517-45DC-BCB7-95C26065DC02Q35618605-958301FF-F0B2-4BA2-97C4-354E42A7FFAAQ35999239-D93D3503-B776-4CC4-92D0-1B51EBCA1F69Q36117569-0D17FB00-6EE2-40F2-ABC2-ADA454CA8F11Q36196285-E0A4DEF5-179D-4D10-AE02-E0670A9C4C04Q36253719-796093B1-5943-4453-ABBC-950A10FF6591Q36304049-DA0574F5-89BA-4D8E-8B61-CDD4223C9F32Q36367098-029CFA5D-F626-4EA7-9EA1-60B9D6420C9AQ36444214-764BA2C9-1F94-47E7-96A0-8312594BB6EEQ36711669-3F742922-582C-4F21-98CF-B98AA4E764B0Q36802764-40DE5505-0B35-436D-84BA-28A7E550F0F6Q36817337-587AE626-D43E-4FC5-8D5C-F0289FDA2B18Q37076282-88FE70F1-8000-48FC-A3D4-49CC39C61E66Q37135829-2144A7AF-39CE-4A34-A3B0-AB16F46FE46B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Emma Loveman
@ast
Emma Loveman
@en
Emma Loveman
@es
Emma Loveman
@nl
Emma Loveman
@sl
type
label
Emma Loveman
@ast
Emma Loveman
@en
Emma Loveman
@es
Emma Loveman
@nl
Emma Loveman
@sl
prefLabel
Emma Loveman
@ast
Emma Loveman
@en
Emma Loveman
@es
Emma Loveman
@nl
Emma Loveman
@sl
P106
P21
P31
P496
0000-0001-8226-2634